Tumor News and Research

RSS

Russian Science Foundation funds eleven Kazan University projects

Eleven Kazan University projects receive funding from the Russian Science Foundation. The results were published on 1st April 2020.

2 Apr 2020

Extracellular forces regulate the formation of epithelia-integrating actomyosin bundles

Different surfaces and organs of the body are covered by epithelial tissue, which is composed of cells tightly connected to each other.

2 Apr 2020

Hereditary genetic defect linked to medulloblastoma destabilizes protein regulation

The causes of 40 percent of all cases of certain medulloblastoma - dangerous brain tumors affecting children - are hereditary.

1 Apr 2020

Immunotherapy may benefit mCRPC patients with specific markers of immune activation

Although metastatic castration-resistant prostate cancer typically has limited response to immunotherapy, a subset of patients with pretreatment evidence of active T-cell responses in their tumors experienced prolonged survival following treatment with ipilimumab in a Phase II trial at The University of Texas MD Anderson Cancer Center.

1 Apr 2020

Understanding hereditary medulloblastomas in children

This is a combined press release between EMBL, the Hopp Children's Cancer Center Heidelberg and the German Cancer Consortium.

1 Apr 2020

Inherited gene mutation can predispose children to SHH medulloblastoma

Investigators at St. Jude Children's Research Hospital, the European Molecular Biology Laboratory, and the German Cancer Research Center have identified ELP1 as a novel predisposition gene in the SHH subgroup of pediatric medulloblastoma.

1 Apr 2020

ERC awards grants to 158 European scientists to identify effective immunotherapy strategies for cancer

The European Research Council (ERC) has announced it will support Professor Thomas Blankenstein to the tune of €2.5 million over five years. This year the ERC is awarding Advanced Grants to a total of 158 scientists across Europe.

1 Apr 2020

Researchers identify new therapeutic strategies against cancer

New findings open up to new therapeutic strategies against cancer. IGC researchers identify signals emitted by the tumor environment, which controls the migrating capacity of cancer cells.

1 Apr 2020

Novel immunotherapy eradicates solid tumors in mice without adverse side effects

Scientists have developed a new immunotherapy that eradicates solid tumors in mice without adverse side effects, according to a new study published today in eLife.

31 Mar 2020

Investigational oral form of treatment offers hope for adults with acromegaly

Adults who need medical maintenance treatment of the growth hormone disorder acromegaly respond well to an investigational oral form of the drug octreotide, investigators of the Chiasma OPTIMAL study reported.

31 Mar 2020

New viable therapeutic strategy found for ER+ breast cancer

Researchers say they have found a viable new therapeutic strategy for estrogen receptor-positive (ER+) breast cancer, even cancers that are resistant to current standard of care treatments.

31 Mar 2020

Potential new method of breast cancer treatment using androgen receptor

Scientists may have discovered a new therapeutic approach to treat ER+ breast cancer using androgen receptor-stimulating drugs.

31 Mar 2020

New blood test detects more than 50 types of cancer, including at early, more treatable stages

Researchers have developed a simple blood test that can detect over 50 types of cancer, often before signs or symptoms.

31 Mar 2020

UVA researchers find way to enhance cancer outcomes by examining patients' genetic data

By mining a vast trove of genetic data, researchers at the University of Virginia School of Medicine are enhancing doctors’ ability to treat cancer, predict patient outcomes and determine which treatments will work best for individual patients.

30 Mar 2020

New blood test accurately detects more than 50 types of cancer

Researchers have developed a blood test that could accurately detect up to 50 types of cancers, and some of these detections could be even before the symptoms appear. The test would help physicians detect the origin or the source of cancer within the body explain the researchers from the European Society of Oncology. The study titled, "Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA," was published in the latest issue of the journal Annals of Oncology.

30 Mar 2020

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

For people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin given by injection, in preventing a repeat venous thromboembolism (VTE), or blood clot, with no excess in major bleeding events, according to Phase 3 trial results presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020

Mount Sinai researchers figure out how to ramp up immune system to prevent tumor growth

Mount Sinai researchers have discovered a pathway that regulates special immune system cells in lung cancer tumors, suppressing them and allowing tumors to grow.

30 Mar 2020

Moffitt scientists identify potential therapeutic targets for cutaneous squamous cell carcinoma

Cutaneous squamous cell carcinoma (cuSCC) is the second most common diagnosed malignancy in the United States, with approximately 700,000 new cases each year.

30 Mar 2020

Research could open up new therapeutic strategies for some lung and kidney cancers

New findings from researchers at The University of Texas MD Anderson Cancer Center about how some cancer cells become "addicted" to glucose could open up fresh approaches to therapy strategies for cancers with high levels of an amino acid transporter called solute carrier family 7 member 11 (SLC7A11).

30 Mar 2020

Weakness in lung and kidney cancer cells could serve as therapeutic target

An important discovery about how some cancers rely on glucose to survive could lead to development of tumor-specific treatments.

30 Mar 2020

Tumor News and Research

Russian Science Foundation funds eleven Kazan University projects

Extracellular forces regulate the formation of epithelia-integrating actomyosin bundles

Hereditary genetic defect linked to medulloblastoma destabilizes protein regulation

Immunotherapy may benefit mCRPC patients with specific markers of immune activation

Understanding hereditary medulloblastomas in children

Inherited gene mutation can predispose children to SHH medulloblastoma

ERC awards grants to 158 European scientists to identify effective immunotherapy strategies for cancer

Researchers identify new therapeutic strategies against cancer

Novel immunotherapy eradicates solid tumors in mice without adverse side effects

Investigational oral form of treatment offers hope for adults with acromegaly

New viable therapeutic strategy found for ER+ breast cancer

Potential new method of breast cancer treatment using androgen receptor

New blood test detects more than 50 types of cancer, including at early, more treatable stages

UVA researchers find way to enhance cancer outcomes by examining patients' genetic data

New blood test accurately detects more than 50 types of cancer

Oral apixaban as effective as dalteparin for treating blood clots in people with cancer

Mount Sinai researchers figure out how to ramp up immune system to prevent tumor growth

Moffitt scientists identify potential therapeutic targets for cutaneous squamous cell carcinoma

Research could open up new therapeutic strategies for some lung and kidney cancers

Weakness in lung and kidney cancer cells could serve as therapeutic target

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News